BullishAgent BullishAgent Filings Market Earnings Ratings IPOs ETFs Insiders
Screener Research
Sign in Register
Portfolio (Quarterly) Guide ↗

Virtus Investment Advisers, LLC

· CIK 0000019481
13F Portfolio $368M AUM Filed Feb 17, 2026 EDGAR ↗ ← All Funds
Q1 2026 Q4 2025 · All 461 New
Page 18 of 24  ·  461 positions
# Ticker Company Sector Shares Value ↓ % Port Chg Shares Chg % Period Price ① Since Period ①
341 PTGX PROTAGONIST THERAPEUTICS INC Healthcare 2,790.0 $244K 0.07% NEW $87.34 +15.3%
342 ELVN ENLIVEN THERAPEUTICS INC Healthcare 15,778.0 $243K 0.07% NEW $15.40 +157.3%
343 BCAX BICARA THERAPEUTICS INC Healthcare 14,395.0 $242K 0.07% NEW $16.83 +19.0%
344 ALLO ALLOGENE THERAPEUTICS INC Healthcare 176,178.0 $241K 0.07% NEW $1.37 +38.0%
345 ACLX ARCELLX INC Healthcare 3,701.0 $241K 0.07% NEW $65.20 +76.5%
346 JANX JANUX THERAPEUTICS INC Healthcare 17,388.0 $240K 0.07% NEW $13.80 +1.7%
347 VIR VIR BIOTECHNOLOGY INC Healthcare 39,764.0 $240K 0.07% NEW $6.03 +45.4%
348 TERN TERNS PHARMACEUTICALS INC Healthcare 5,912.0 $239K 0.07% NEW $40.40 +31.1%
349 ZBIO ZENAS BIOPHARMA INC Healthcare 6,554.0 $238K 0.07% NEW $36.31 -53.4%
350 MGTX MEIRAGTX HLDGS PLC Healthcare 29,824.0 $237K 0.06% NEW $7.95 +18.2%
351 MLTX MOONLAKE IMMUNOTHERAPEUTICS Healthcare 17,987.0 $237K 0.06% NEW $13.18 +24.7%
352 SOLENO THERAPEUTICS INC 5,116.0 $237K 0.06% NEW $46.30
353 MONOPAR THERAPEUTICS INC 3,565.0 $233K 0.06% NEW $65.30
354 ORIC ORIC PHARMACEUTICALS INC Healthcare 28,361.0 $232K 0.06% NEW $8.18 -3.1%
355 SVRA SAVARA INC Healthcare 38,443.0 $232K 0.06% NEW $6.03 -18.6%
356 FULC FULCRUM THERAPEUTICS INC Healthcare 20,463.0 $231K 0.06% NEW $11.31 -46.2%
357 CGEM CULLINAN THERAPEUTICS INC Healthcare 22,318.0 $231K 0.06% NEW $10.35 +37.0%
358 KYMR KYMERA THERAPEUTICS INC Healthcare 2,966.0 $231K 0.06% NEW $77.81 +2.4%
359 DISC MEDICINE INC 2,897.0 $230K 0.06% NEW $79.41
360 GOSS GOSSAMER BIO INC Healthcare 73,896.0 $229K 0.06% NEW $3.10 -93.6%
Page 18 of 24  ·  461 positions

Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.

Sector Allocation
Healthcare 25.9%
Financial Services 25.7%
Technology 17.4%
Industrials 10.0%
Consumer Cyclical 7.5%
Communication Services 4.3%
Energy 2.6%
Real Estate 2.5%
Consumer Defensive 1.8%
Basic Materials 1.5%